| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.538 | 15.343 | 16.662 | 7.908 | 10.262 |
| Total Income - EUR | - | - | - | - | - | 7.538 | 15.343 | 16.662 | 7.908 | 10.262 |
| Total Expenses - EUR | - | - | - | - | - | 2.350 | 7.907 | 9.110 | 13.974 | 10.092 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.188 | 7.436 | 7.552 | -6.066 | 170 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.961 | 6.985 | 7.062 | -6.066 | -93 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vasile Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 133 | 680 | 334 | 130 | 130 |
| Current Assets | - | - | - | - | - | 5.133 | 7.144 | 7.848 | 1.983 | 1.970 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 406 | 403 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 402 |
| Cash | - | - | - | - | - | 5.133 | 7.144 | 7.848 | 1.577 | 1.164 |
| Shareholders Funds | - | - | - | - | - | 5.003 | 7.026 | 7.103 | 1.015 | 916 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 263 | 798 | 1.079 | 1.098 | 1.183 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vasile Med S.r.l.